Urine metabolomics analysis for improved risk classification and treatment of chronic kidney disease patients; a NTNU - UCSD collaboration
The role of mitochondrial in diabetic kidney disease
Current Diabetes Reports 2016, in press
Targeted metabolomics reveals that TCA metabolites are reduced in non-diabetic CKD and increases with paricalcitol.
Under review in Kidney International
Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria.
Clin Proteomics 2015 Aug 7;12(1):21.